KRISTIN FOLEY: Open Payments
NPI 1346697711 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,001 in 51 payments from 15 companies in 2025. Trend: 2023 $1,640 · 2024 $892 · 2025 $1,001
Food & beverage: $1,001
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 13 | $156 |
| ARS Pharmaceuticals Operations, Inc. | 8 | $136 |
| Pharming Healthcare, Inc. | 5 | $121 |
| GENZYME CORPORATION | 3 | $96 |
| Optinose US, Inc. | 4 | $91 |
| AstraZeneca Pharmaceuticals LP | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| CSL Behring | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
Products named: DUPIXENT, TRELEGY ELLIPTA, NEFFY, RUCONEST, Xhance, Hizentra, TAKHZYRO, DAWNZERA.
Industry payments across TX — which companies pay providers there.
